|
시장보고서
상품코드
2038976
GMP 단백질(대장균) 수탁제조 시장 : 제품 유형별, 용도별, 제조 방법별, 최종사용자별, 지역별GMP Protein (E. Coli) Contract Manufacturing Market, By Product Type, By Application, By Method, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
GMP 단백질(대장균) 수탁제조 시장은 2026년에 20억 5,000만 달러로 추정되고 있으며, 2033년에 47억 8,000만 달러에 달할 것으로 전망되고 있습니다. 2026-2033년에는 CAGR 12.8%로 성장할 것으로 예측됩니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 20억 5,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 12.80% | 2033년 시장 규모 예측 : | 47억 8,000만 달러 |
GMP 단백질(대장균)은 단백질의 특성에 따라 동물 유래 성분을 포함하지 않는 공정으로 제조될 수도 있고 그렇지 않을 수도 있습니다. 재조합 단백질은 유전자 발현과 메신저 RNA의 번역을 지원하는 시스템으로 복제된 재조합 DNA에 의해 코드화된 단백질입니다. 재조합 DNA 기술에 의한 유전자 변형은 돌연변이 단백질의 생산으로 이어질 수 있습니다. 박테리아에서 공동 발현된 단백질에는 인산화나 당쇄 부가 등의 번역 후 변형이 일어나지 않습니다. 의약품으로 제조 및 상품화된 재조합 단백질에는 휴마린, 헤마토로프, 아보넥스, 코제네이트, 팔모자임 등이 있습니다.
시장 역학
시장에서의 제품 출시 증가는 예측 기간 중 글로벌 GMP 단백질(E. coli) 수탁제조 시장의 성장을 촉진할 것으로 예상됩니다. 예를 들어 고품질 생명과학 연구용 시약 및 서비스를 제공하는 AMSBIO는 2022년 6월 세포치료용 재조합 단백질 제품군인 'Stem Fit Protein'을 출시할 예정이라고 밝혔습니다. 'Stem Fit Protein' 시리즈에는 췌장, 심장, 신장, 혈액, 면역세포에서 배아줄기세포(ES세포)와 인공다능성줄기세포(iPS세포)의 분화에 중요한 역할을 하는 재조합 단백질이 포함되어 있습니다. 또한 2021년 9월에는 생명과학 연구용 항체, 면역측정 키트 및 재조합 단백질을 제공하는 Aviva Systems Biology가 기초 연구 및 전임상 시험을 수행하는 생명과학자들을 위한 새로운 'Protein on Demand' 세미 커스텀 GMP 재조합 단백질 포트폴리오를 출시한다고 발표했습니다. 30만 종 이상의 단백질을 포괄하는 'Protein on Demand' 포트폴리오를 통해 연구진은 맞춤형 단백질의 중소규모 생산을 신속하게 이용할 수 있습니다.
본 조사의 주요 특징
- 이 보고서는 다양한 부문의 잠재적 매출 창출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요 인사이트를 제공합니다.
- 이 보고서에서는 다음과 같은 매개변수(기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 기반으로 세계의 GMP 단백질(대장균) 수탁제조 시장의 주요 기업을 분석합니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 세계의 GMP 단백질(대장균) 위탁 생산 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 글로벌 GMP 단백질(대장균) 수탁제조 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 범위
제3장 시장 역학, 규제, 동향 분석
제4장 세계의 GMP 단백질(대장균) 수탁제조 시장 : 제품 유형별, 2020-2033년
제5장 세계의 GMP 단백질(대장균) 수탁제조 시장 : 용도별, 2020-2033년
제6장 세계의 GMP 단백질(대장균) 수탁제조 시장 : 제조 방법별, 2020-2033년
제7장 세계의 GMP 단백질(대장균) 수탁제조 시장 : 최종사용자별, 2020-2033년
제8장 세계의 GMP 단백질(대장균) 수탁제조 시장 : 지역별, 2020-2033년
제9장 경쟁 구도
제10장 섹션
KSA 26.06.01GMP Protein (E. Coli) Contract Manufacturing Market is estimated to be valued at USD 2.05 Bn in 2026 and is expected to reach USD 4.78 Bn by 2033, growing at a compound annual growth rate (CAGR) of 12.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2.05 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 12.80% | 2033 Value Projection: | USD 4.78 Bn |
GMP Protein (E. coli) may or may not be manufactured using animal-free processes depending on the characteristics of the protein. Recombinant Protein is a protein encoded by a gene recombinant DNA that has been cloned in a system that supports the expression of the gene and translation of messenger RNA. Modification of the gene by recombinant DNA technology can lead to the expression of a mutant protein. Proteins co-expressed in bacteria will not possess post-translational modifications, e.g. phosphorylation or glycosylation. Some of the recombinant proteins which were produced and commercialized in medications are Humulin, Hematrope, Avonex, Kogenate, Pulmozyme and others.
Market Dynamics
Increasing launches of products in the market is expected to drive the growth of the global GMP protein (E. coli) contract manufacturing market over the forecast period. For instance, in June 2022, AMSBIO, a provider of quality life science research reagents and services, announced the launch of its Stem Fit Protein range of recombinant proteins for cell therapy applications. The Stem Fit Protein range includes recombinant proteins that play key roles in differentiating Embryonic Stem (ES) and induced Pluripotent Cells (iPS) in the pancreas, heart, kidney, blood, and immune cells. Moreover, in September 2021, Aviva Systems Biology, a company providing antibodies, immunoassay kits, and recombinant proteins for life science research, announced the launch of its new Protein on Demand semi-custom GMP grade recombinant protein portfolio for life scientists conducting basic research and preclinical studies. The Protein on Demand portfolio of over 300,000 proteins allows rapid access to small- to mid-scale production of customized proteins for research teams.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global GMP protein (E. coli) contract manufacturing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Merck & Co., Inc., Thermo Fisher Scientific Inc., Abcam plc, GenScript, Biomay AG, SOL GROUP, Proteintech Group, Inc., Nordmark Pharma GmbH, Sino Biological, Inc., Sino Biological, Inc., Abnova Corporation, Eurofins Scientific, Arcline Investment Management LP, Abgenex, Xpress Biologics, Avid Bioservices Inc, Bio-Techne, Northway Biotech, Aldevron, Institut Merieux, PerkinElmer Inc., Creative BioMart, Profacgen, ProBioGen AG, 53Biologics, Leadgene Biomedical, Inc., Ajinomoto Bio-Pharma, FUJIFILM Diosynth Biotechnologies, Avioq, Inc, Biovian Oy, KBI Biopharma, GTP Bioways, QIAGEN, Suzhou Novoprotein Technology Co., Ltd., ACROBiosystems, Kactus, F. Hoffmann-La Roche Ltd., and Enzo Life Sciences, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global GMP protein (E. coli) contract manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global GMP protein (E. coli) contract manufacturing market.
Market Segmentation
- Global GMP Protein (E. coli) Contract Manufacturing Market, By Product Type
- Cytokines
- Growth Factors
- Enzymes
- DNA polymerase
- Protease
- Trypsin
- Nuclease
- Benzonase
- Cas9 Nucleases
- Others
- IVT Enzymes
- Others
- Hormones
- Antigens
- Others
- Global GMP Protein (E. coli) Contract Manufacturing Market, By Application:
- Gene Therapy
- Cell Therapy
- Global GMP Protein (E. coli) Contract Manufacturing Market, By Method:
- In-Vivo
- Ex-Vivo
- Global GMP Protein (E. coli) Contract Manufacturing Market, By End User:
- Biotechnology and Pharmaceutical Companies
- Academic & Research Institutes
- Contract Research Organizations
- Others
- Global GMP Protein (E. coli) Contract Manufacturing Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Key Players
- Merck & Co., Inc.,
- Thermo Fisher Scientific Inc.
- Abcam plc
- GenScript
- Biomay AG
- SOL GROUP
- Proteintech Group, Inc.
- Nordmark Pharma GmbH
- Sino Biological, Inc.
- Abnova Corporation
- Eurofins Scientific
- Arcline Investment Management LP
- Abgenex
- Xpress Biologics,
- Avid Bioservices Inc
- Bio-Techne,
- Northway Biotech
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Method
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- PEST Analysis
- Porter's Analysis
- Key Developments
- Regulatory Scenario
- Acquisition and Agreement Scenario
- Brand Mapping
4. Global GMP Protein (E. coli) Contract Manufacturing Market, By Product Type, 2020 - 2033, (US$ Billion)
- Overview
- Market Share Analysis, 2022 and 2033 (%)
- Y-o-Y Growth Analysis, 2020 - 2033
- Segment Trends
- Cytokines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (US$ Billion)
- Growth Factors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (US$ Billion)
- Enzymes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (US$ Billion)
- DNA polymerase
- Protease
- Trypsin
- Nuclease
- Benzonase
- Cas9 Nucleases
- Others
- IVT Enzymes
- Others
- Hormones
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (US$ Billion)
- Antigens
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (US$ Billion)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (US$ Billion)
5. Global GMP Protein (E. coli) Contract Manufacturing Market, By Application, 2020 - 2033, (US$ Billion)
- Overview
- Market Share Analysis, 2022 and 2033 (%)
- Y-o-Y Growth Analysis, 2020 - 2033
- Segment Trends
- Gene Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (US$ Billion)
- Cell Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (US$ Billion)
6. Global GMP Protein (E. coli) Contract Manufacturing Market, By Method, 2020 - 2033, (US$ Billion)
- Overview
- Market Share Analysis, 2022 and 2033 (%)
- Y-o-Y Growth Analysis, 2020 - 2033
- Segment Trends
- In-Vivo
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (US$ Billion)
- Ex-Vivo
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (US$ Billion)
7. Global GMP Protein (E. coli) Contract Manufacturing Market, By End User, 2020 - 2033, (US$ Billion)
- Overview
- Market Share Analysis, 2022 and 2033 (%)
- Y-o-Y Growth Analysis, 2020 - 2033
- Segment Trends
- Biotechnology and Pharmaceutical Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (US$ Billion)
- Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (US$ Billion)
- Contract Research Organizations
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (US$ Billion)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (US$ Billion)
8. Global GMP Protein (E. coli) Contract Manufacturing Market, By Region, 2020 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2022 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2020-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Method, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2033, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Method, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2033, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Method, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2033, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Method, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2033, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Method, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2033, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Method, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2033, (US$ Billion)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Merck & Co., Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abcam plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GenScript
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Biomay AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- SOL GROUP
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Proteintech Group, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Nordmark Pharma GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sino Biological, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Kaneka Eurogentec S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abnova Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eurofins Scientific
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Arcline Investment Management LP.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abgenex
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Xpress Biologics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Avid Bioservices, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bio-Techne
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Northway Biotech
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Aldevron
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Institut Merieux
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- PerkinElmer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Creative BioMart
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Profacgen
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ProBioGen AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- 53Biologics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Leadgene Biomedical, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Ajinomoto Bio-Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- FUJIFILM Diosynth Biotechnologies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Avioq, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Biovian Oy
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- KBI Biopharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GTP Bioways
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- QIAGEN
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Suzhou Novoprotein Technology Co., Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ACROBiosystems
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Kactus
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- F. Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Enzo Life Sciences, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
10. Section
- Research Methodology
- About Us
